Skip to main content
Colette Owens, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

ColetteNgoziOwensMD

Oncology New York, NY

Hematologic Oncology

Assistant Attending at Memorial Sloan Kettering Cancer Center

Overview of Dr. Owens

Dr. Colette Owens is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Hackensack Meridian Health Riverview Medical Center, and Memorial Sloan Kettering Monmouth. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 7 years. She is one of 466 doctors at Memorial Sloan Kettering Cancer Center and one of 45 doctors at Hackensack Meridian Health Riverview Medical Center who specialize in Oncology. She has more than 20 publications and over 400 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2010

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NY State Medical License
    NY State Medical License 2012 - 2025
  • NJ State Medical License
    NJ State Medical License 2016 - 2025

Publications & Presentations

PubMed

Abstracts/Posters

  • Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...
    Colette Owens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
    Colette Owens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
    Colette Owens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Challenges of Managing Older Patients with Diffuse Large B-cell Lymphoma
    Challenges of Managing Older Patients with Diffuse Large B-cell LymphomaSeptember 10th, 2018

Hospital Affiliations